- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
UPDATED Jun 15, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
956 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CMCX | UK£2.58 | -3.6% | 54.0% | UK£718.7m | UK£1.79 | PE71x | E46.9% | 1.9% | Diversified Financials | ||
SPZ | AU$0.48 | 4.3% | 81.1% | AU$167.9m | n/a | PE24.8x | E32.6% | n/a | Commercial Services | ||
CAPMAN | €1.89 | -0.4% | -27.7% | €335.0m | €2.30 | PE94.8x | E35.1% | 5.3% | Diversified Financials | ||
2233 | HK$1.09 | -6.0% | 29.8% | HK$5.9b | HK$1.41 | PE13.1x | E46.9% | 2.3% | Materials | ||
2273 | HK$42.20 | 0.4% | -21.9% | HK$10.3b | HK$64.59 | PE38x | E28.9% | n/a | Healthcare | ||
A104460 | ₩19,960.00 | -0.05% | -7.4% | ₩192.9b | ₩28,000.00 | PE23x | E39.1% | 1.0% | Capital Goods | ||
A260930 | ₩8,620.00 | 19.9% | 39.3% | ₩162.4b | n/a | PE50x | E62.1% | 1.2% | Household | ||
A119610 | ₩24,900.00 | 0% | -30.0% | ₩312.1b | ₩43,250.00 | PE27.1x | E58.4% | 2.4% | Healthcare | ||
300040 | CN¥7.00 | -1.7% | 12.2% | CN¥4.1b | n/a | PE48.7x | E63.8% | 1.0% | Capital Goods | ||
ALVU | €14.70 | -7.3% | 38.7% | €141.5m | €18.00 | PE19.9x | E21.3% | 2.9% | Retail | ||
KIE | UK£1.36 | -3.7% | 69.6% | UK£615.0m | UK£1.93 | PE15.3x | E22.4% | 2.5% | Capital Goods | ||
NEXN | UK£2.47 | -3.7% | -12.6% | UK£341.7m | UK£10.00 | PS1.3x | E115.8% | 0% | Media | ||
CARE | US$12.13 | -4.2% | -21.4% | US$279.2m | US$15.00 | PB0.8x | E32.8% | 0% | Banks | ||
1523 | HK$2.88 | 0.7% | 28.6% | HK$3.2b | HK$3.75 | PE14.4x | E13.8% | 6.2% | Tech | ||
SRV1V | €5.78 | -6.8% | 47.8% | €97.9m | €4.60 | PB0.7x | E68.9% | 0% | Capital Goods | ||
MUSTI | €25.50 | 1.4% | 36.1% | €851.4m | €24.00 | PE54.6x | E38.5% | 2.4% | Retail | ||
GALD | CHF74.99 | 2.2% | n/a | CHF17.8b | CHF76.20 | PS4.9x | E42.9% | n/a | Pharmaceuticals & Biotech | ||
A103590 | ₩25,550.00 | 9.0% | 181.1% | ₩1.2t | ₩30,000.00 | PE33.7x | E37.5% | 0.9% | Capital Goods | ||
300143 | CN¥7.38 | 0.7% | -31.8% | CN¥4.7b | CN¥10.12 | PE53.7x | E28.5% | 0% | Healthcare | ||
ATEB | €5.88 | -3.1% | -79.1% | €255.3m | €13.40 | PS2.9x | E116.0% | 0% | Real Estate Management and Development | ||
HXL | US$62.25 | -6.5% | -13.7% | US$5.2b | US$76.00 | PE52x | E23.2% | 1.0% | Capital Goods | ||
HNVR | US$16.49 | 1.5% | -5.4% | US$119.5m | US$18.50 | PB0.6x | E20.9% | 2.4% | Banks | ||
GIGA | kr3.78 | -1.3% | -63.6% | kr216.2m | kr11.00 | PS1.2x | E78.0% | n/a | Utilities | ||
RECV3 | R$18.07 | -5.2% | -5.3% | R$5.3b | R$29.45 | PE8.6x | E23.7% | 3.0% | Energy |